Th1/Tc1 immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Th1/Tc1 immunotherapy, covering 2018-10-16 to 2018-10-16. Get the full timeline:
Most recent: Clinical Trial Update: Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma [Phase 1, Phase 2]